尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Notice of the Annual General Meeting And of Meeting of the Shareholders of H Shares
2024-05-28
(1) Change of Auditors(2) General Mandate to Issue A Shares(3) Authorisation of 2024 Interim Profit Distribution Proposal(4) Amendments to Articles of Association and (5) Notice of Meetings
2024-05-28
2023 Environmental, Social and Governance Report
2024-04-25
Unaudited First Quarter Results of 2024
2024-04-25
Annual Report 2023
2024-04-24
Announcement for 2023 Annual Results
2024-03-28
Unaudited Quarterly Results Announcement For The Nine Months Ended 30 September
2023-10-27
2023 Interim Report
2023-09-18
2023 Interim Results Announcement
2023-08-24
Final Dividend For The Year Ended 31 December 2022
2023-06-26
<
1
2
3
4
5
6
7
...
>